Non-small cell lung cancer

Common Name(s)

Non-small cell lung cancer

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Non-small cell lung cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Non-small cell lung cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Non-small cell lung cancer" returned 3414 free, full-text research articles on human participants. First 3 results:

Ceritinib in ALK-rearranged non-small-cell lung cancer.
 

Author(s): Alice T Shaw, Jeffrey A Engelman

Journal: N. Engl. J. Med.. 2014 Jun;370(26):2537-9.

 

Last Updated: 26 Jun 2014

Go To URL
Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer.
 

Author(s): Masayuki Aboshi, Masayuki Kaneko, Mamoru Narukawa

Journal: J. Cancer Res. Clin. Oncol.. 2014 May;140(5):839-48.

 

New treatment strategies, particularly the introduction of molecular-targeted agents and appropriate patient selection based on histology and/or genotyping, have progressed markedly in recent years, and the overall survival (OS) in advanced non-small cell lung cancer (NSCLC) patients ...

Last Updated: 11 Apr 2014

Go To URL
Optimizing collimator margins for isotoxically dose-escalated conformal radiation therapy of non-small cell lung cancer.
 

Author(s): Samantha Warren, Vanessa Panettieri, Niki Panakis, Nicholas Bates, Jason F Lester, Pooja Jain, David B Landau, Alan E Nahum, W Philip M Mayles, John D Fenwick

Journal: Int. J. Radiat. Oncol. Biol. Phys.. 2014 Apr;88(5):1148-53.

 

Isotoxic dose escalation schedules such as IDEAL-CRT [isotoxic dose escalation and acceleration in lung cancer chemoradiation therapy] (ISRCTN12155469) individualize doses prescribed to lung tumors, generating a fixed modeled risk of radiation pneumonitis. Because the beam penumbra ...

Last Updated: 25 Mar 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Non-small cell lung cancer" returned 407 free, full-text review articles on human participants. First 3 results:

Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data.
 

Author(s):

Journal: Lancet. 2014 May;383(9928):1561-71.

 

Individual participant data meta-analyses of postoperative chemotherapy have shown improved survival for patients with non-small-cell lung cancer (NSCLC). We aimed to do a systematic review and individual participant data meta-analysis to establish the effect of preoperative chemotherapy ...

Last Updated: 5 May 2014

Go To URL
[Progress of platelet derived grow factor family in non-small cell lung cancer].
 

Author(s): Yijun Tian, Qian Chu, Yuan Chen

Journal: Zhongguo Fei Ai Za Zhi. 2014 Jan;17(1):42-8.

 

Non-small cell lung cancer (NSCLC) is a malignant tumour with quite high cancer specific mortality, and it still lacks stable and reliable markers for NSCLC's prognosis. Platelet derived grow factor (PDGF) and PDGFR has been considered to be involved in the process of cell proliferation, ...

Last Updated: 8 Jan 2014

Go To URL
[Progress in immunotherapy for non-small cell lung cancer].
 

Author(s): Yan Xu, Mengzhao Wang

Journal: Zhongguo Fei Ai Za Zhi. 2014 Jan;17(1):34-41.

 

In recent years, the five-year survival rate of patients with advanced stage non-small cell lung cancer (NSCLC) remains low despite recent advances in surgery, irradiation, chemotherapy, and targeted therapy. Immunotherapy which utilizes the immune system to control and eradicate ...

Last Updated: 8 Jan 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation
 

Status: Recruiting

Condition Summary: Cachexia; Fatigue; Pulmonary Complications; Radiation Toxicity; Recurrent Non-small Cell Lung Cancer; Stage IIIA Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer

 

Last Updated: 28 Mar 2014

Go to URL
Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II
 

Status: Recruiting

Condition Summary: Non-small Cell Lung Cancer; Advanced Non-small Cell Lung Cancer; Recurrent Non-small Cell Lung Cancer

 

Last Updated: 15 May 2014

Go to URL
Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer
 

Status: Recruiting

Condition Summary: Non-small Cell Lung Cancer; Progression of Non-small Cell Lung Cancer; Non-small Cell Lung Cancer Recurrent

 

Last Updated: 1 Jul 2014

Go to URL